Centrus Energy (LEU) Q1 2026 earnings review
Top-Line Growth Obscures Heavy Expansion Costs
Centrus beat revenue expectations with a 5% YoY increase to $76.7M and raised full-year guidance. However, the top-line success didn't translate to the bottom line. GAAP Net Income plummeted 63% to $10.0M, driven by a massive $15.9M spike in advanced technology costs as the company heavily invests in its Oak Ridge centrifuge manufacturing plant. The transition into 'full execution mode' is draining cash, but surging SWU (Separative Work Unit) prices and a 47% jump in Technical Solutions revenue show the core business fundamentals remain solid.
🐂 Bull Case
Despite a 47% drop in SWU volume sold, segment revenue held steady due to a massive 52% increase in average SWU pricing. The supply-constrained market is working heavily in Centrus's favor.
Management bumped FY26 revenue guidance to $450-$500M based on commercial progress, signaling confidence in delivery schedules and the DOE HALEU contract performance.
🐻 Bear Case
Operating cash flow turned deeply negative (-$35.1M) as the company stockpiled $48.8M in inventory and ramped up capital deployment for its facility expansion.
With $350-$500M in capital deployment planned for 2026, any supply chain hiccups, partner delays (Fluor), or cost overruns will severely punish the balance sheet.
⚖️ Verdict: ⚪
Neutral. The core macro thesis for domestic uranium enrichment is playing out perfectly (higher prices, DOE support), but the financial reality of building heavy industrial infrastructure is temporarily crushing margins and cash flow.
Key Themes
Technical Solutions Segment Taking Flight
Accelerating. Revenue from Technical Solutions surged 47% YoY to $32.1M. This is a direct result of the DOE HALEU operation contract signed in 2022. As the U.S. government pushes for domestic advanced reactor fuel, this segment is transitioning from a secondary revenue stream to a primary growth engine.
Operating Cash Flow Plunges into the Red
Reversing. A major red flag: despite reporting $10M in Net Income, Operating Cash Flow collapsed to negative $35.1M (compared to +$36.5M in Q1 2025). This massive divergence was driven by a $48.8M increase in inventories. While management might attribute this to production ramp-up or timing of deliveries, burning this much cash from operations while embarking on a massive CapEx cycle puts pressure on the balance sheet.
Advanced Technology Costs Crushing Net Margins
Decelerating. Advanced technology costs skyrocketed to $18.9M from $3.0M a year ago. These are non-capitalizable growth costs tied to the Oak Ridge and Piketon expansions. Until these projects come online or hit capitalization milestones, they will continue to severely drag down GAAP profitability.
Palantir AI Partnership to Drive Efficiency
A newly announced partnership with Palantir integrates their AI platform into Centrus's operations. The early results are highly promising: Centrus claims to have already identified ~$300M in potential cost savings and timeline accelerations for the centrifuge manufacturing program. If successfully executed, this represents a massive tech-driven margin expansion opportunity.
Geopolitical Macro Tailwinds Continue
Stable. CEO Amir Vexler explicitly cited "global conflicts and rising tensions" as the primary macro driver accelerating the diversification away from Russian fossil fuels and enriched uranium. This geopolitical shift validates Centrus's $3.9B backlog and long-term expansion thesis.
HALEU Phase 2 Definitization Delays
While Technical Solutions revenue grew, profitability is being temporarily constrained. Due to a delay in completing Phase 2 of the DOE contract, the period was extended. Costs incurred since November 2024 are still under negotiation and have not yet been subject to a fee, capping the segment's gross profit potential until the government signs off.
SWU Pricing Power
Stable. The LEU segment saw a 47% drop in the volume of SWU sold, but this was nearly entirely offset by a 52% increase in the average price of SWU. The ability to command drastically higher prices proves the severe supply-demand imbalance in the Western uranium enrichment market.
Other KPIs
Stable. The backlog extends to 2040 and is split between $3.1B in LEU (including $2.4B in contingent sales tied to the Piketon expansion) and $0.8B in Technical Solutions. This provides massive long-term visibility, assuming contingent contracts convert to firm orders.
Decelerating. Cash dropped slightly from $1.96B at year-end 2025 due to negative operating cash flow and $23.2M in capital expenditures. However, the war chest remains highly robust to fund the impending build-out without immediate dilution.
Guidance
Accelerating. The guidance was revised upward from the previous $425-$475M range based on strong commercial progress. The $475M midpoint implies a solid ~5.8% YoY growth compared to FY25's $448.7M.
Accelerating dramatically. Driven by increased investment in the industrial build-out of centrifuge manufacturing in Oak Ridge and Piketon. This represents a historic step-up in spending for the company.
Key Questions
Palantir AI Savings Realization
You highlighted ~$300M in potential cost savings identified by Palantir's AI platform. How much of this will realistically be realized in FY26, and will it show up as reduced CapEx or improved operating margins?
Definitization of HALEU Phase 2
Costs incurred after November 2024 for the HALEU DOE contract are currently un-fee'd. What is the timeline for concluding these negotiations, and should we expect a retroactive margin bump when completed?
Inventory Strategy and Cash Flow
With operating cash flow turning negative due to a $48.8M inventory buildup, is this level of working capital intensity the new normal for the next few quarters as you prepare for the Oak Ridge expansion?